| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |